An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The findings indicate that the currently approved 600-mg dose of intravenous ocrelizumab is optimal to significantly slow ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called ...

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of "More Stamina," a gamified mobile health (mHealth) app designed to help people with multiple sclerosis ...

A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of drugs originally developed to treat lymphomas and related blood disorders, ...